Shuchi Nahar's Weekend Blog!

 Indoco Remedies Ltd. - Company Overview Twitter Handle: @shuchi_nahar 1. Company Profile The company was established in 1947. Indoco is a small-sized pharma company engaged in manufacture, marketing and distribution of pharmaceutical products and services in the domestic & international markets. Through its nine marketing divisions viz. Indoco, Spade, Warren NexGen, Warren ACE, Warren Excel and Vision, Indoco Focus, Indoco CND, Spera and Institution the company serves a range of doctor specialties. Indoco has signed supply agreements with companies like Watson, Aspen and DSM to supply formulations to advanced and emerging markets. Figure:1 Graph Showing Revenue Trend & Revenue Breakup 2. India formulations growth core to overall growth Domestic formulations (~63% of FY20 revenues) grew at 6.5% CAGR in FY16-20. The subdued growth can be attributed to high concentration of acute therapies and one of the lowest MR productivities. With a market share of ~0.7% and overall rank o

Indian Pharmaceutical Industry Outlook Shuchi.P.Nahar The pharmaceutical sector is at a crossroads. In a heavily disrupted marketplace, characterized by shifting payer attitudes and patient empowerment, neither incremental adjustments nor steady evolution are likely to halt the decline of the traditional pharmaceutical business model. This paper looks ahead to a 2030 scenario to examine the trends revolutionizing the sector trends that we expect to have dramatic impacts.  The Indian pharmaceutical industry has contributed immensely not just to Indian but to global healthcare outcomes. India continues to play a material role in manufacturing various critical, high‐ quality and low‐cost medicines for Indian and global markets. It supplies 50 to 60 % of global demand for many vaccines (including ARVs), 40 % of generics consumed in the US and 25 percent of all the medicines dispensed in the UK . Over the last 5 years, 35 to 38 % of total ANDAs approved (including 25 to 30 percen

Weekend BLOG 4                                                                                                      Shuchi.P.Nahar Disclaimer: So in this blog I have tried to summarize my learning from various research reports justifying the road map for pharma companies in India. All credits to content writers and various reports that are worth reading to have an extra-ordinary idea about pharma sector growth and expansion ahead. Pharma Sector Growth Ahead-2020 The Indian pharmaceuticals market has characteristics that make it unique.  First, branded generics dominate, making up for 70 to 80 per cent of the retail market.  Second, local players have enjoyed a dominant position driven by formulation development capabilities and early investments.  Third, price levels are low, driven by intense competition.  While India ranks 10th globally in terms of value, it is ranked 3rd in volumes. These characteristics present their own opportunities and challenges. An expanding